Avi Eliassaf
Director de Operaciones en Anima Biotech, Inc. .
Cargos activos de Avi Eliassaf
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Director de Operaciones | - | - |
Historial de carrera de Avi Eliassaf
Antiguos cargos conocidos de Avi Eliassaf.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Director Financiero/CFO | - | - |
Formación de Avi Eliassaf.
Ben-Gurion University of the Negev | Undergraduate Degree |
Estadísticas
Internacional
Israel | 3 |
Estados Unidos | 2 |
Operativa
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sectorial
Distribution Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Distribution Services |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Avi Eliassaf
- Experiencia